COMPANY
Bolden Therapeutics
NIH awards 5
- NIH award 1R43AG084445-01A1 FY2024: $504,505 awarded for that fiscal year; activity R43 (SBIR); PI VALAT, ANNE; recipient as written: BOLDEN THERAPEUTICS, INC., Providence, RI. Preclinical characterization of splice- source ↗
- NIH award 3R41AG073144-01A1S1 FY2023: $396,914 awarded for that fiscal year; activity R41 (STTR); PI FALLON, JUSTIN R.; recipient as written: BOLDEN THERAPEUTICS, INC., Providence, RI. Promoting adult hippocampal neu source ↗
- NIH award 1R43AG078719-01 FY2022: $406,466 awarded for that fiscal year; activity R43 (SBIR); PI VALAT, ANNE; recipient as written: BOLDEN THERAPEUTICS, INC., Providence, RI. Entrepreneurial development award for a n source ↗
- NIH award 1R43AG078093-01 FY2022: $497,550 awarded for that fiscal year; activity R43 (SBIR); PI VALAT, ANNE; recipient as written: BOLDEN THERAPEUTICS, INC., Providence, RI. Promoting adult hippocampal neurogenesis source ↗
- NIH award 1R41AG073144-01A1 FY2021: $500,000 awarded for that fiscal year; activity R41 (STTR); PI VALAT, ANNE; recipient as written: BOLDEN THERAPEUTICS, INC., Providence, RI. Promoting adult hippocampal neurogenesi source ↗